scPharmaceuticals Inc. (NASDAQ: SCPH) Stock Information | RedChip

scPharmaceuticals Inc. (NASDAQ: SCPH) Listen to this Section


$5.19
+0.1300 ( +2.57% ) 365.4K

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Market Data


Open


$5.19

Previous close


$5.06

Volume


365.4K

Market cap


$187.12M

Day range


$5.06 - $5.29

52 week range


$3.24 - $8.05

Insider Ownership Transactions

Total Amount Purchased: -224,470.00 | $ -1,164,999.30

Date Type Amount Purchased Purchaser
2024-08-08 Sale -10445.00 Nokes Rachael
2024-06-13 Sale -19750.00 Agger Mette Kirstine
2024-06-13 Sale -19750.00 Khattar Jack A.
2024-06-13 Sale -19750.00 Abraham William Tober
2024-06-13 Sale -19750.00 VEITINGER KLAUS R DR
2024-06-13 Sale -19750.00 Baylor-Henry Minnie
2024-06-13 Sale -19750.00 Bonstein Sara
2024-06-13 Sale -19750.00 SCHAEFFER LEONARD D
2024-06-13 Sale -19750.00 Hudson Frederick M.
2024-04-02 Sale -56025.00 Tucker John H

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 15, 2024
10-q Quarterly Reports 71 Aug 14, 2024
8-k 8K-related 14 Aug 14, 2024
8-k 8K-related 18 Aug 13, 2024
8-k 8K-related 20 Aug 12, 2024
4 Insider transactions 1 Aug 08, 2024
8-k 8K-related 13 Jun 14, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.